Cadence Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Cadence Capital Management’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-140,772	Closed	-$1.62M	–	471
2018 Q4	$1.62M	Buy	140,772 +10,970	+8%	+$187K	0.16%	191
2018 Q3	$2.81M	Buy	129,802 +61,994	+91%	+$1.17M	0.15%	174
2018 Q2	$1.07M	Sell	67,808 -21,608	-24%	-$340K	0.06%	375
2018 Q1	$1.69M	Buy	+89,416	New	+$1.76M	0.11%	250

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cadence Capital Management's ARA Position: Q1 2019 in Review

Cadence Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2019, closing a stake of 140,772 shares — an estimated $1.62M sold.

Cadence Capital Management first reported a position in ARA in Q1 2018 and held it in 4 quarters. The position peaked at $2.81M in Q3 2018. 68 funds tracked by Wall St. Rank hold ARA as of Q1 2019.

Cadence Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2019 after selling out during the quarter.
Cadence Capital Management sold 140,772 American Renal Associates Holdings, Inc shares in Q1 2019, an estimated $1.62M.
Cadence Capital Management first reported a position in American Renal Associates Holdings, Inc in Q1 2018 and held it in 4 quarters.
Cadence Capital Management's American Renal Associates Holdings, Inc position peaked at $2.81M in Q3 2018.
68 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2019.

Based on Cadence Capital Management's 13F filing for Q1 2019, filed 7 May 2019.